As the value of medtech deals increases, investors are increasingly looking for earlier opportunities. COVID-19 has added both impetus and new opportunity, with innovators and investors vying to build a position in digital health technologies, such as remote monitoring and digital therapeutics.
According to Medtech Insight’s Venture Capital Funding Tracker, over $6bn has been invested in medtech ventures since January 2021, divided between 80 deals.
For comparison, in the whole of 2019, approximately $2.3bn was spent by venture capital in medtech over 86 deals, and...